KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Invested Capital (2016 - 2022)

Arbutus Biopharma's Return on Invested Capital history spans 5 years, with the latest figure at 0.5% for Q4 2022.

  • For Q4 2022, Return on Invested Capital changed N/A year-over-year to 0.5%; the TTM value through Dec 2022 reached 0.5%, changed N/A, while the annual FY2022 figure was 0.46%, N/A changed from the prior year.
  • Return on Invested Capital for Q4 2022 was 0.5% at Arbutus Biopharma, down from 0.46% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.38% in Q3 2018 and bottomed at 1.8% in Q4 2019.
  • The 3-year median for Return on Invested Capital is 0.45% (2022), against an average of 0.62%.
  • The largest YoY upside for Return on Invested Capital was 118bps in 2018 against a maximum downside of 118bps in 2018.
  • A 3-year view of Return on Invested Capital shows it stood at 0.38% in 2018, then crashed by -369bps to 1.8% in 2019, then soared by 72bps to 0.5% in 2022.
  • Per Business Quant, the three most recent readings for ABUS's Return on Invested Capital are 0.5% (Q4 2022), 0.46% (Q3 2022), and 0.43% (Q2 2022).